EMERYVILLE, Calif., April 14 /PRNewswire/ -- Nanomix Inc., a leading nanotechnology company commercializing a line of nanoelectronic detection devices for industrial and biomedical applications, today announced that it has been awarded a $500,000 National Science Foundation (NSF) grant. The Phase II Small Business Innovation Research (SBIR) award will be used to develop a collaborative development kit based on its versatile Sensation TM detection platform. The development kit will enable collaborators to work together with Nanomix on application development of analyte specific recognition chemistry.
During Phase I of the NSF SBIR project, Nanomix demonstrated their ability to produce the platform as well as delivered a functioning prototype of the test equipment and data acquisition software. "We are pleased to have the support of the National Science Foundation in this endeavor. Through the use of the development kit, Nanomix collaborators will gain access to ultra-sensitive nanoelectronic detection technology that cannot be obtained elsewhere," said Dr. Jean-Christophe Gabriel, the Principal Investigator on the NSF sponsored project.
Nanomix is collaborating with scientists at several universities, as well as with industrial partners on the definition and evaluation of the collaborative development kit. These partners are working with Nanomix on detection applications ranging from medical diagnostics, water and air quality monitoring. "We are excited about our continued collaboration with the National Science Foundation," said David Macdonald, President and CEO of Nanomix, "by making Sensation TM technology readily available, we will encourage collaborators to work with us to explore new applications that leverage the platform."
Nanomix is a leading nanotechnology company launching a menu of devices based on Sensation(TM) detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistries. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanodetection technology -- low power consumption, small form factor, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Additional information is available at http://www.nano.com/.
CONTACT: public relations, Melita Wenger, +1-415-362-4022, for Nanomix;or David Macdonald, President and CEO of Nanomix, +1-510-428-5300